You are here

Home 🌿 Cannabis Technology News 🌿 AXIM Biotech Announces Launch of Clinical Trials on MedChew RX(TM) and Development of Pharmaceutical-Grade Cannabis Chewing Gum 🌿

AXIM Biotech Announces Launch of Clinical Trials on MedChew RX(TM) and Development of Pharmaceutical-Grade Cannabis Chewing Gum

Submitted by Marijuana News on Tue, 08/11/2015 - 20:47

Global Industrial Hemp Bioscience Company Announces Clinical Trials at Free University of Amsterdam, The Netherlands

 

SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products – all derived from industrial hemp. AXIM Biotech is pleased to announce that the Company has started clinical development of its leading patented pharmaceutical chewing gum, MedChew RX™, for registration as a drug for patients suffering from pain and/or spasticity associated with multiple sclerosis (MS).

Once approved by the FDA (Food and Drug Administration) and EMA (European Medicines Agency), MedChew RX – formulated with 5 mg of cannabidiol (CBD) and 5 mg of tetrahydrocannabinol (THC) – will be marketed as a pharmaceutical drug for multiple sclerosis (MS).

Traditional cannabinoid delivery methods such as smoking, oral / GI route with reduced...

Rate this article: 
Region: 
United States
Netherlands
California

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://money.cnn.com/news/newsfeeds/articles/globenewswire/10145580.htm

420 Intel is Your Source for Marijuana News

420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.

420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.

Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.

You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.